Trial intelligence / Profile preview

Nebulized furosemide adjunctive therapy in stable chronic obstructive pulmonary disease

PACTR202106917652038Not yet recruiting

Sponsor
Medical Research Institute Alexandria University
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of furosemide in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Medical Research Institute Alexandria University. Planned start Jul 2021; status: not yet recruiting.

02

Drugs

furosemide
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on PACTR202106917652038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202106917652038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call